We would like to inform that the Board of Directors in its meeting held on 01.02.200 had: taken on record the resolution passed by the Companys wholly-owned subsidiary for sale transfer or disposal of its domestic business assets constituting its pharmaceutical formulations brands in India and Nepal including related trademarks copyrights and such other intellectual property as may be agreed inventories etc. to Mankind Pharma Limited (Buyer) and/or subsidiaries of Buyer; and approved the said Transaction.In the said meeting the Board had also convened an Extra-ordinary General Meeting of the Company on Saturday February 26 2022 at 11.30 AM through Video Conferencing / Other Audio-Visual Means.The meeting of the Board of Directors commenced at 11:30 A.M. and concluded at 12:15 P.M.
Ask Value Research 
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.
